Rpflx Webbanner

MALDI-TOF Mass Spectrometry and its impact on High-Throughput Screening

Join Bruker's workshop at Discovery Technologies 2018


Bruker proudly presents its workshop at Discovery Technologies. This is your chance to learn more about the application of novel emerging technologies that are reshaping drug discovery.


"Label-free Mass Spectrometry: from Imaging to High-Throughput Screening with MALDI-TOF-MS”

May 22, 2018 3:00 pm - 05:00 pm, Room: Helix 2

  • Label-free high-throughput screening for unambiguous hit identification
  • Measurement of unmodified substrates and products in primary screens to avoid false positives
  • Up to 30 masses simultaneously
  • Game changing cost per sample



3:00 pm – Welcome
Dr. Meike Hamester, Bruker Daltonics Bremen, Germany

3:10 pm - High-throughput screening for imaging and HTS at GlaxoSmithKline
Peter Marshall, PhD, GSK, UK

3:35 pm - MALDI-TOF MS: A label-free technology for high-throughput screening
Dr. Martin Winter, Boehringer Ingelheim, Germany

4:00 pm - MALDI TOF mass spectrometry for cell based Screening
Dr. Bogdan Munteanu - University of Mannheim, Germany

- SAMDI technology: An innovative approach to high-throughput mass spectrometry 
Zachary A. Gurard-Levin, PhD, SAMDI Tech, Inc., USA

4:50 pm - Discussion

You can also take the opportunity to discuss with our experts the advantages of mass spectrometry instrumentation for high-throughput screening in drug discovery.

Visit us on booth No. 7 on May 23, 2018.

We look forward to seeing you in Cheshire.

Bruker Daltonics Team

For further information, please contact:
Anne Kropp-Schnisa
Bruker Daltonik GmbH
Fahrenheitstrasse 4
28359 Bremen

Venue Info:
Alderley Park Conference Centre

Discovery Technologies 2018

Stay informed!

Newsletter registration

LinkedIn registration